Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Repare Therapeutics
450 Kendall St
Cambridge, MA 02142
http://www.reparerx.com/

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare's platform combines a proprietary, high-throughput, CRISPR-enabled gene editing target discovery method with high-resolution protein crystallography, computational biology and clinical informatics.

Key Contact
NameTitleE-Mail
Lloyd M. SegalPresident & CEOlsegal@reparerx.com


Funding Events
DateAmountTypeInvestors
06/22/17$68,000,000Series A BDC Capital Healthcare Venture Fund
Celgene Corporation
Fonds de solidarite FTQ
MPM Capital  
Versant Ventures  
09/05/19$82,500,000Series B BDC Capital Healthcare Venture Fund
BVF Partners
Cowen Healthcare Investments  
Fonds de solidarite FTQ
Logos Capital
MPM Capital
OrbiMed US
Redmile Group
Versant Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.